中山大学眼科中心 provides medical services specializing in ophthalmology, including treatment for various eye diseases and educational programs in the field. The center is described as the largest public ophthalmology hospital in China.

中山大学眼科中心

Aier Eye Hospital Group Co., Ltd. operates eye care hospitals and institutions. The company offers medical services in the areas of fundus diseases, optometry, refractive correction, glaucoma, corneal diseases, and cataract. It also provides training course for cataract prevention and treatment. The company operates approximately 500 ophthalmic hospitals in mainland China, 86 ophthalmic hospitals in Europe, 1 ophthalmic hospital in the United States, 7 ophthalmic hospitals in Hong Kong, and 12 ophthalmic hospitals in Southeast Asia. The company was founded in 2007 and is headquartered in Changsha, China.

Aier Eye Hospital Group Co., Ltd.

AIMLEAP is a business intelligence solutions company that provides IT and data engineering services using innovative technology. The company's self-described capabilities include on-demand data, data analytics, and application modernization.

AIMLEAP

Royal Fern offers plant-based skincare products, including skincare, haircare, and supplements. It utilizes a patented formulation, the Royal Fern Complex, to enhance skin's protective barrier and provide hydration.

Metric
Company Name	中山大学眼科中心	Aier Eye Hospital Group Co., Ltd.	AIMLEAP	Royal Fern
Symbol		300.01K
MSH ID	COM:GZZOC	COM:AIERCHINA	COM:AIMLEAP	COM:ROYALFERN
Market	PRIVATE	STOCKS	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare	Technology	Consumer Goods
Industry	Healthcare	Medical - Care Facilities	Information Technology	Cosmetics
Country	CN	CN	US	DE
Stage
Employee Count		36.72K
Website	gzzoc.com	aierchina.com	aimleap.com	royalfern.com
LinkedIn
Founders

Metric
Market Cap	13.82B
Enterprise Value
Monthly Web Traffic		3.26K
Web Traffic Growth		0.37
Valuation
Raised Capital

Metric
Revenue		2.80B
Revenue (LTM)
Revenue (NTM)
Gross Profit		1.42B
EBITDA		916.96M
Operating Income		680.57M
Net Income		462.00M
EPS		0.05
Diluted EPS		0.05
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin		0.51
Operating Profit Margin		0.24
EBITDA Margin		0.33
Net Profit Margin		0.18
Return on Equity		0.19
Return on Assets		0.12
Return on Capital Employed		0.20

COM:GZZOC

中山大学眼科中心

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio		28.49
P/B Ratio		5.02
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio		8.54
EV Multiple		30.24

Metric
Days Sales Outstanding		44.15
Days Payables Outstanding		87.27
Days Inventory Outstanding		35.19
Operating Cycle		77.10
Cash Conversion Cycle		4.44
Asset Turnover		0.66

Metric
Operating Cash Flow		807.65M
Free Cash Flow		606.88M
Cash Flow to Debt		2.09
Operating Cash Flow/Sales		0.27
Free Cash Flow Yield		0.03

Metric
Cash & Equivalents		838.90M
Accounts Receivable
Inventory		123.75M
Goodwill		898.56M
Debt to Capitalization		0.22
Debt to Assets		0.15
Current Ratio		1.70
Quick Ratio		1.71

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue		0.02
SG&A to Revenue		0.04